Adult COVID, Flu, and RSV Vaccination Trends from National Survey

National Immunization Survey Adult COVID Module (NIS-ACM) data tracks uptake and confidence for the 2024-25 COVID-19, seasonal flu, and RSV vaccines. It provides trends in vaccination status and intent by demographics and other characteristics. The CDC provides this data, with records starting in September 2024.

Use Cases

• Analyze temporal trends in 'Estimate (%)' for different 'Vaccine' types across 'Time Period' and 'Year'.
• Compare vaccination 'Indicator Name' metrics like intent or uptake across 'Group Category' and 'Group Name' such as age or race.
• Assess geographic disparities by analyzing 'Estimate (%)' and its '95% CI (%)' across different 'Geography' types and names.
• Model factors influencing vaccine confidence using 'Indicator Category' and demographic 'Group' columns.
• Track data quality and reliability using the 'Suppression Flag' and 'Sample Size' columns for each record.

Strengths

• Includes confidence intervals ('95% CI (%)') for each estimate, allowing for statistical reliability assessment.
• Covers three major vaccine types (COVID-19, flu, RSV) within a single survey framework.
• Provides data at multiple 'Geography' types and levels for spatial analysis.
• Data is updated regularly, with a last update recorded in May 2025.

Limitations

• Specific sample sizes ('Sample Size') and total row counts are not provided, limiting assessment of statistical power.
• Data begins in September 2024, offering a limited initial time range for longitudinal analysis.
• Potential for non-response bias inherent in survey data collection methods.

Provenance

Source

Centers for Disease Control and Prevention (CDC) via data.cdc.gov.

Collection Method

National Immunization Survey Adult COVID Module (NIS-ACM), a public health survey.

Time Range

From September 2024 onward.

Freshness

Updated as of 2025-05 16.

Geography

United States, with data at multiple 'Geography' types.